Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Attenuation of the Side Effect Profile of Regadenoson: Study With Aminophylline in Patients Undergoing Myocardial Perfusion Imaging (ASSUAGE)

This study has been completed.
Information provided by (Responsible Party):
Rami Doukky, Rush University Medical Center Identifier:
First received: November 29, 2010
Last updated: November 27, 2012
Last verified: November 2012